Abstract:BackgroundPreoperative imaging assessment of venous malformations (VMs) and prediction of foam sclerotherapy efficacy might be achievable by DCE‐MRI but elaborate quantitive analysis was absent.PurposeTo evaluate the value of DCE‐MRI in predicting the effectiveness of foam sclerotherapy in VMs.Study TypeRetrospective.PopulationFifty‐five patients (M:F = 17:38; mean age ± SD, 15.4 ± 13.0 years) with VMs.Field Strength/SequenceThree Tesla MRI with 3D T1‐weighted volume interpolated body examination.AssessmentPatients who underwent pretreatment DCE‐MRI were divided into “effective” and “ineffective” groups according to the response to foam sclerotherapy. Clinical characteristics and morphologic features were assessed. The semiquantitative parameters, such as maximum intensity time ratio (MITR), enhancement ratio (ER), and Slope, were obtained from ROI and volume of interest (VOI). The quartile and mean values of these parameters were acquired from VOI, while mean values denoted as Mean# were acquired from ROI. Establishment of two predictive models was based on ROI and VOI respectively. Model 1 was based on morphologic parameters and ROI semiquantitative parameters, while model 2 was based on morphologic parameters and VOI semiquantitative parameters.Statistical AnalysisMann–Whitney U‐test, Cohen's kappa, multivariate logistic regression analysis (backward stepwise), and ROC analyses.ResultsThe lesion classification, presence of phlebolith, semiquantitative parameters of VOI (quartile and mean of MITR), and semiquantitative parameters of ROI (Slopemean#, MITRmean#) were significantly different between two groups. Lesion classification (P = 0.002) and MITRmean# (P = 0.027) were independent predictors for poor efficacy in model 1 as determined by multivariate binary logistic regression analysis. For model 2, lesion classification (P = 0.006) and MITR25 (P = 0.001) were independent predictors. The predictive model based on VOI (AUC = 0.961) performed better than that based on ROI (AUC = 0.909) in predicting therapeutic response.Data ConclusionDCE‐MRI is promising in predicting the response to foam sclerotherapy for VMs. The whole lesion VOI‐based model showed better performance and could instruct surgical approach in the future.Evidence Level3Technical EfficacyStage 4

Efficacy Evaluation of Sclerotherapy for Venous Malformations on Head and Neck Region Based on ROI-volumentry of MRI Assessment by Three-dimensional Reconstruction Measurement

Proven Protocol of Embolization and Sclerotherapy for Venous Malformation of Perineum

Three-Dimensional Volumetric Analysis of Venous Malformations for Assessing the Effectiveness of Percutaneous Sclerotherapy

Sclerotherapy of Voluminous Venous Malformation in Head and Neck with Absolute Ethanol under Digital Subtraction Angiography Guidance.

Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome.

Treatment of Residual Venous Malformations after Surgical Resection Using Interventional Sclerotherapy

Multiparametric Magnetic Resonance Imaging Features That Predict Treatment Response to Endovascular Sclerotherapy in Craniofacial Venous Malformations

Efficacy of Sclerotherapy with Radio-Opaque Foam Guided by Digital Subtraction Angiography for the Treatment of Complex Venous Malformations of the Head and Neck

Value of Dynamic Contrast‐Enhanced (DCE) MRI in Predicting Response to Foam Sclerotherapy of Venous Malformations

Clinical Effect of Radiofrequency Ablation Combined with Digital Subtraction Angiography-Guided Percutaneous Ethanol Injection Sclerotherapy in the Management of High-Return Flow Venous Malformation

Whole-lesion assessment of volume and signal changes after sclerotherapy of extremity venous malformations

Outcomes and complications of sclerotherapy for venous malformations.

MR-guided Percutaneous Sclerotherapy of Venous Vascular Malformations of the Extremities

Efficacy and Safety of Sclerotherapy with Polidocanol Foam for Superficial Venous Malformation

Sclerotherapy of venous malformation in the head and neck region with absolute ethanol under the guide of DSA

Interim Results of Bleomycin-Polidocanol Foam Sclerotherapy As a Highly Efficient Technique for Venous Malformations.

Efficacy and safety of hyaluronic-polidocanol foam in sclerotherapy for head and neck venous malformations

Complications and prevention of ethanol sclerotherapy for venous malformation in head and neck

Sclerotherapy of venous malformation in children：selection of method and its technique

Percutaneous Sclerotherapy of Large Venous Malformations Using Consecutive Polidocanol and Bleomycin Foam: MR Imaging Volumetric and Quality-of-Life Assessment